Trial intelligence / Profile preview

Collagenase for Debridement in Pressure Ulcers

NCT02004626Phase 3Withdrawn

Sponsor
Cristália
Start
Jan 2015
Primary completion
Jun 2015
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 3 trial of collagenase clostridium histolyticum in pressure ulcer, sponsored by Cristália. Planned start Jan 2015; status: withdrawn.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

pressure ulcer

Beyond the preview

Go deeper on NCT02004626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02004626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call